NRG1 Type III (extracellular) Blocking Peptide (#BLP-NR113) is the original antigen used for immunization during Anti-NRG1 Type III (extracellular) Antibody (#ANR-113) generation. The blocking peptide binds and ‘blocks’ Anti-NRG1 Type III (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of rat dorsal root ganglion lysate:
- Western blot analysis of rat brain membranes (lanes 1 and 3) and mouse brain membranes (lanes 2 and 4):
- Mouse brain sections (Gatius, A. et al. (2020) Front. Cell. Neurosci. 13, 582.).
- (C)DKIFEYDSPTHLD, corresponding to amino acid residues 101-113 of human Neuregulin-1 Type III (Accession Q02297).